Viewing nowHypertelmi Tablet 80mg (Telmisartan)
Telmisartan 80mg
Tablet · Prescription medication
Korea Hyutecs Pharmaceutical Co., Ltd.

MFDS item code 201702216 · Approved 2017.04.28 · Insurance code 649103430
Treatment of essential hypertension and prevention of cardiovascular disease in high-risk patients
This medication is used to effectively control blood pressure in patients with essential hypertension. Additionally, it helps to decrease the risk of myocardial infarction, stroke, and death from cardiovascular diseases in high-risk patients aged 55 and older. It is particularly applied as an alternative therapy for patients who cannot use ACE inhibitors. This medication contributes to improving vascular health and reducing the likelihood of cardiovascular diseases, thereby reducing overall mortality risk. Therefore, it is effectively used for managing hypertension and reducing cardiovascular risks.
1. Essential hypertension Adults: Telmisartan should be administered orally at 40 mg once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after treatment is initiated. When this medicine is administered concomitantly with thiazide diuretics such as hydrochlorothiazide, it has an additional blood pressure-lowering effect. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at 80 mg once daily with water and may be taken with or without food. The risk-reducing effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild to moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication may cause serious harm, especially to the fetus and newborn during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used by individuals with known allergies to this drug or any of its components, pregnant or breastfeeding women, patients with severe liver disease, those with a history of hereditary angioedema, and patients with certain kidney diseases. Elderly patients, those with hyperkalemia, liver disease, and heart disease should take this medication with caution, as there is a risk of excessively low blood pressure or worsening kidney function. This drug may cause various side effects such as infections, blood abnormalities, allergic reactions, hyperkalemia, hypoglycemia, neurological symptoms, irregular heartbeats, low blood pressure, dyspnea, gastrointestinal issues, liver dysfunction, skin rashes, myalgia, and kidney impairment. In particular, serious adverse reactions such as angioedema or acute renal failure, interstitial pneumonia, and rhabdomyolysis may occur, so patients should consult healthcare professionals immediately if symptoms arise. Kidney function and serum electrolyte levels should be monitored regularly while taking this medication, and if blood pressure drops too low, the patient should be reclined and intravenous therapy should be considered if necessary. Interactions can occur when taken in conjunction with other antihypertensives or certain medications, so it is essential to inform the doctor or pharmacist of any other medications being taken. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women are also advised to avoid it. Safety and efficacy in children and adolescents have not been established, so it is not recommended for this age group. In case of overdose, symptoms such as low blood pressure, dizziness, and acute renal failure may appear, so immediate contact with healthcare professionals and proper treatment is necessary. This medication should be stored out of reach of children, and it is safest to open the package just before use.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a sealed container. The recommended storage temperature is room temperature between 1 degree and 30 degrees Celsius. This will help maintain the effectiveness and safety of the medication.
White or nearly white, double-convex round tablets
30 tablets/blister [10 tablets/blister × 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 80mg
Tablet · Prescription medication
Korea Hyutecs Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.